Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s disease-Reference-Cited by-同舟云学术

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s disease

Published:2000-08 Issue:1-2 Volume:113 Page:199-206
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Maelicke Alfred,Schrattenholz Andre,Samochocki Marek,Radina Martin,Albuquerque Edson X

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference64 articles.

1. Nicotinie-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity;Akaike;Brain Res.,1994

2. Properties of neuronal nicotinic acetylcholine receptors, pharmacological characterization and modulation of synaptic function;Albuquerque;J. Pharmacol. Exp. Ther.,1996

3. Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity;Albuquerque;Prog. Brain Res.,1996

4. Choline is a selective agonist of α7 nicotinic acetylcholine receptors;Alkondon;Eur. J. Neurosci.,1997

5. Alkondon M, Pereira EFR, Eisenberg H, Albuquerque EX. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. J Neurosci (1999), in press.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Treatment and Management of Alzheimer’sDisease: A Precision Medicine Perspective;Current Topics in Medicinal Chemistry;2024-07

2. Evaluation of galantamine and deconstructed analogs as α7 nAChR and AChE ligands;Results in Chemistry;2022-01

3. Nicotinic acetylcholine receptors: Diversity and physiological importance for neurodegenerative disorders and development of organophosphate antidotes;Periodicum Biologorum;2020-12-30

4. Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators;Neuropharmacology;2020-05

5. QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine;Therapeutic Advances in Drug Safety;2020-01